Market Overview
Centesis catheters are specialized medical devices designed for minimally invasive drainage of excess fluid from body cavities, including the pleural space, peritoneal cavity, and pericardium. The market encompasses various catheter types used in diagnostic and therapeutic procedures performed in hospital and outpatient settings. Industry reports consistently value the global market between $490 million and $630 million in 2024, with projections extending toward $740 million to $890 million by 2030, depending on methodology and geographic scope.
- •Market valued at approximately $0.59 billion in 2025 with steady upward trajectory
- •Procedures include thoracentesis, paracentesis, and pericardiocentesis for fluid management
- •Growth supported by increasing hospital procedures and outpatient adoption
Growth Drivers
The primary market catalyst is the rising global prevalence of chronic diseases that produce pathological fluid accumulation, particularly cardiovascular disorders and liver cirrhosis. An aging population increases incidence rates of these conditions, expanding the patient pool requiring centesis procedures. Additionally, the shift toward minimally invasive techniques over surgical interventions drives adoption of catheter-based solutions due to reduced recovery times and lower complication rates.
- •Cardiovascular disease and liver cirrhosis remain the dominant clinical indications
- •Aging demographics and rising obesity rates contribute to higher procedure volumes
- •Minimally invasive preference over open surgical drainage supports market expansion
Segmentation and Regional Analysis
The market segments by product type, including drainage catheters, pigtail catheters, and trocar catheters, as well as by application, end-user, and geography. North America and Europe currently hold the largest market shares due to established healthcare infrastructure and higher procedure adoption rates. The Asia-Pacific region is emerging as the fastest-growing segment, driven by improving healthcare access, rising disease burden, and increasing medical device expenditure in countries such as China and India.
- •Product categories include drainage, pigtail, and trocar catheter designs
- •North America leads in market share, followed by Europe
- •Asia-Pacific represents the highest growth opportunity due to expanding healthcare access
Trends and Outlook
What are the recent trends and outlook?
The market is expected to maintain steady growth through 2030, with long-term projections reaching approximately $740 million to $890 million depending on regional adoption rates and product innovation cycles. Emerging trends include the development of antimicrobial-coated catheters to reduce infection risk and the integration of imaging guidance technologies to improve procedural accuracy. Value-based healthcare models and cost containment pressures may influence product pricing and procurement strategies, while expanded indications for catheter drainage in critical care and oncology settings could open new application areas.
- •Projected market range of $740 million to $890 million by 2030
- •Antimicrobial coatings and imaging-guided insertion represent innovation frontiers
- •Value-based procurement and expanded clinical applications may reshape market dynamics
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.